Thursday, January 12, 2017 7:39:37 PM
https://staticseekingalpha1.a.ssl.fastly.net/uploads/sa_presentations/300/4300/slides/26.jpg?1484237754
This is the first time they have listed partnership as part of 12 month milestones. They've mentioned partnerships before but in other contexts, maybe under strategy, but never under 12 month milestones. What's also worthy of noting is partnership(s) for "melanoma and solid tumor indications." If these are going to be with one big pharma (MRK), I believe we can expect a decent deal amount. My bet is on NSCLC.
Given patient enrollment for melanoma registration trial is expected to start in Q2 2017, I expect the long-awaited partnership to be announced this quarter.
As for TRACE, as hschlauch has written about it, and as Punit also said during yesterday's presentation, it seems ready to be used for combinations beyond anti-PD1 agents. Will be exciting to find out who their collaborators are going to be on this one. If I had to guess, KU Leuven and a big pharma will team up on something.
Looking forward to these inflection points this year.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM